Compare DNLI & TRMK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DNLI | TRMK |
|---|---|---|
| Founded | 2013 | 1889 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.3B |
| IPO Year | 2017 | 1987 |
| Metric | DNLI | TRMK |
|---|---|---|
| Price | $18.14 | $40.45 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 3 |
| Target Price | $32.58 | ★ $42.67 |
| AVG Volume (30 Days) | ★ 1.7M | 269.0K |
| Earning Date | 11-06-2025 | 01-27-2026 |
| Dividend Yield | N/A | ★ 2.36% |
| EPS Growth | N/A | ★ 10.82 |
| EPS | N/A | ★ 3.66 |
| Revenue | N/A | ★ $773,338,000.00 |
| Revenue This Year | N/A | $58.57 |
| Revenue Next Year | $3,993.60 | $4.65 |
| P/E Ratio | ★ N/A | $11.10 |
| Revenue Growth | N/A | ★ 55.58 |
| 52 Week Low | $10.57 | $29.77 |
| 52 Week High | $24.35 | $41.34 |
| Indicator | DNLI | TRMK |
|---|---|---|
| Relative Strength Index (RSI) | 51.69 | 62.20 |
| Support Level | $17.20 | $37.37 |
| Resistance Level | $20.61 | $41.22 |
| Average True Range (ATR) | 1.03 | 1.13 |
| MACD | -0.21 | 0.22 |
| Stochastic Oscillator | 29.72 | 85.65 |
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.
Trustmark Corp is a bank holding company. Through its subsidiaries, the company operates as a financial services organization providing banking and other financial solutions in Alabama, Florida, Mississippi, Tennessee, and Texas. Its principal products and services include Commercial Banking, Consumer Banking, Mortgage Banking, Insurance, Wealth Management and Trust Services, and others. The company is managed along two operating segments: General Banking and Wealth Management. The General Banking segment, which generates the majority of the revenue, provides all traditional banking products and services, including loan deposits, and also consists of internal operations.